Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-03-26 @ 3:16 PM
NCT ID:
NCT07401303
Eligibility Criteria:
Inclusion Criteria:
* scheduled to undergo ESD for an early gastric cancer (the indication for ESD under current guidelines)
* both genders aged 18-75 years
* no pretreatment (ESD, surgery, radiation therapy, or chemotherapy) performed on the stomach to be examined
* platelet count of \>10×10\^9/L and hemoglobin count of \>8.0 g/L in blood tests performed in the 3 months before the ESD
* "antithrombotic drugs" have been withdrawn for the period recommended by current guidelines
* written consent provided at the patient's discretion
Exclusion Criteria:
* scheduled for hybrid ESD
* scheduled for ESD due to multiple lesions
* scheduled for treatment of lesions with residual recurrence
* presence of submucosal tumors
* unable to discontinue an antithrombotic drugs at the time of informed consent
* inherited or acquired coagulopathy likely to affect the risk of bleeding
* receiving maintenance dialysis
* deemed unsuitable for participation in this study by the principal investigator or other investigators
* unable to provide informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT07401303
Study Brief:
Protocol Section:
NCT07401303